No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
644 |
6. Filter based on genotype QC (FinnGen only) |
644 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Acute myeloid leukaemia and myelodysplastic syndromes
based on the number of shared cases.
Similar with more cases:
- Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 644 | 251 | 393 |
| Unadjusted period prevalence (%) | 0.14 | 0.09 | 0.17 |
| Median age at first event (years) | 72.44 | 70.30 | 73.81 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494434) Karyotype in Bone marrow
210
50
61.84
307.65
1.4
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
204
85
34.66
299.38
5.5
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
109
31
42.12
177.17
1.3
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
109
34
38.39
172.57
2.7
2.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
121
52
28.42
172.44
1.7
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
315
625
8.91
170.62
17.1
3.6
u/l
324.2
258.9
1.67
301
585
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
118
58
24.68
159.25
1.5
1.6
u/ml
104.3
97.2
0.26
33
11
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
120
67
21.78
153.14
1.4
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
121
72
20.46
149.86
13.1
5.8
iu/ml
931.9
520.5
0.43
21
12
(3027945) Reticulocytes/100 erythrocytes in Blood
302
659
7.75
146.56
8.0
2.4
%
1.9
1.8
0.68
281
594
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
115
68
20.37
142.66
1.3
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
111
65
20.43
138.21
1.4
1.3
u/ml
255.8
273.9
0.12
71
34
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
146
140
13.19
138.21
1.9
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
251
477
7.98
138.16
7.7
2.4
e9/l
68.7
67.6
0.06
208
390
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
107
59
21.55
136.92
4.2
4.7
u/ml
615.2
668.1
—
11
7
(3048929) Epstein Barr virus Ab [Presence] in Serum
125
96
15.92
135.27
1.4
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
111
78
16.99
125.86
1.3
1.1
u/l
169.6
43.4
3.15
92
68
(3017181) Myelocytes/100 leukocytes in Blood
209
381
7.64
117.97
11.6
3.9
%
1.8
0.8
2.41
136
116
(3004809) Band form neutrophils/100 leukocytes in Blood
105
75
16.53
117.81
10.3
3.4
%
1.2
1.6
0.24
86
63
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
169
270
8.13
106.95
2.0
1.8
g/l
1.3
1.6
2.82
144
236
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
118
124
11.43
103.96
3.9
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
87
58
17.19
100.87
1.2
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
176
312
7.39
100.87
3.4
2.5
g/l
10.0
10.4
0.53
166
283
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
113
122
11.02
97.47
4.3
1.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
57
14
44.57
95.04
4.7
2.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
55
14
42.86
90.85
4.5
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
96
92
12.09
89.67
4.3
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
79
60
14.87
85.03
1.2
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
138
231
7.33
82.56
1.4
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
170
357
6.11
81.02
12.1
4.0
%
0.2
0.1
0.75
123
107
(3028026) IgM [Mass/volume] in Serum or Plasma
142
254
6.89
79.60
1.5
1.6
g/l
1.2
1.5
0.73
136
231
(3002179) Metamyelocytes/100 leukocytes in Blood
164
342
6.09
78.58
12.0
3.8
%
1.1
0.4
2.95
83
88
(3008757) Leukocyte morphology finding [Identifier] in Blood
74
59
14.04
77.30
12.3
3.9
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
78
68
12.91
77.17
8.7
5.6
mg/l
10.5
12.6
2.50
73
62
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
46
12
41.21
75.28
2.1
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
67
48
15.46
74.31
10.3
3.0
%
43.1
54.0
1.46
40
36
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
54
27
21.74
71.20
1.8
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
164
378
5.48
69.84
1.6
1.5
—
—
—
0
0
(44790047)
65
51
14.06
68.38
2.3
1.6
—
—
—
0
0
(44790049)
65
51
14.06
68.38
2.3
1.6
—
—
—
0
0
(44806118)
65
51
14.06
68.38
2.3
1.6
—
—
—
0
0
(44790048)
65
51
14.06
68.38
2.3
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
176
448
5.03
66.48
2.6
2.5
g/l
66.0
65.7
0.20
166
405
(3025159) Blasts/100 leukocytes in Blood
151
338
5.53
66.24
12.0
4.0
%
4.2
0.1
2.30
93
92
(3024471) HLA-A [Type]
70
7
112.00
65.31
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
70
7
112.00
65.31
1.4
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
61
0
+∞
64.69
1.0
0.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
70
69
11.26
63.67
2.3
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
167
424
4.97
63.01
1.6
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
50
28
19.28
62.58
1.2
1.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
214
663
4.34
62.51
12.9
5.4
mmol/l
1.1
1.0
1.26
205
601
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
64
57
12.36
62.21
2.5
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
60
49
13.40
61.53
5.4
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
61
52
12.85
60.93
5.3
1.7
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
39
12
34.53
60.83
1.2
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
83
113
8.28
58.99
4.2
3.1
%
92.0
87.4
0.95
83
107
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
72
88
9.09
55.80
1.8
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
334
1497
3.56
55.30
26.9
5.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
46
28
17.62
55.24
1.5
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
46
28
17.62
55.24
1.5
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
57
53
11.70
53.75
1.2
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
44
26
18.09
53.57
7.9
4.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
169
511
4.13
49.92
1.6
1.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
216
777
3.68
49.53
11.6
3.3
mmol/l
0.8
0.8
0.56
203
720
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
42
27
16.57
48.99
7.1
1.6
e6/l
356.7
714.9
1.09
21
14
(3026493) Urate [Moles/volume] in Serum or Plasma
280
1233
3.25
45.75
8.6
2.8
umol/l
329.5
9433.8
6.44
267
1033
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
46
40
12.31
45.17
1.8
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
134
371
4.30
44.23
2.0
2.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
139
397
4.19
43.99
3.6
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
41
33
13.20
42.16
7.6
1.5
e9/l
1.0
1.0
0.06
21
15
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
56
71
8.54
41.94
1.8
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
46
47
10.46
40.52
6.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
46
47
10.46
40.52
6.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
46
47
10.46
40.52
6.0
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
49
55
9.56
40.32
4.0
2.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
368
2024
2.91
38.56
23.9
5.5
%
0.6
0.6
0.18
354
1875
(3019069) Monocytes/100 leukocytes in Blood
376
2095
2.91
38.38
26.6
5.7
%
10.8
8.8
4.70
360
1948
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
43
7
65.65
37.61
1.2
1.0
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
373
2085
2.87
37.58
24.9
5.5
%
1.9
2.8
8.20
358
1928
(3002030) Lymphocytes/100 leukocytes in Blood
378
2139
2.86
37.00
25.8
5.7
%
32.7
26.0
13.09
361
1977
(3018677) aPTT in Platelet poor plasma by Coagulation assay
202
817
3.15
36.90
5.0
2.1
s
29.2
30.0
0.96
193
787
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
35
29
12.71
35.28
7.1
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
35
29
12.71
35.28
7.1
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
35
29
12.71
35.28
7.1
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
35
29
12.71
35.28
7.1
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
34
27
13.24
35.15
1.2
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
32
23
14.59
35.01
7.5
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
32
23
14.59
35.01
7.5
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
25
11
23.60
34.25
2.2
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
32
24
13.98
34.18
7.5
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
50
72
7.44
33.52
2.0
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
301
1587
2.68
32.69
17.0
4.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
77
173
4.92
32.68
2.2
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
37
6
65.27
32.39
1.2
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
51
82
6.67
30.87
1.9
1.5
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
30
24
13.06
30.82
2.1
2.7
%
37.2
42.2
—
11
10
(3018010) Neutrophils/100 leukocytes in Blood
359
2104
2.60
30.79
22.9
5.5
%
47.7
58.6
27.14
341
1956
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
28
20
14.59
30.67
2.9
1.7
%
20.7
16.8
—
13
10
(3020779) Urea [Moles/volume] in Serum or Plasma
134
470
3.34
30.54
8.5
6.7
mmol/l
9.1
11.3
2.17
128
445
(3013862) HLA-DP [Type]
29
0
+∞
30.45
1.0
0.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
290
1544
2.60
30.30
18.6
2.5
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
28
0
+∞
29.39
1.0
0.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
28
0
+∞
29.39
1.0
0.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
28
0
+∞
29.39
1.0
0.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
28
0
+∞
29.39
1.0
0.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
29
24
12.61
29.17
1.4
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
87
237
4.09
28.81
2.4
1.8
ug/l
6.5
2.9
0.48
75
209
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
204
937
2.72
28.48
4.1
1.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
32
34
9.85
27.27
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
26
20
13.50
27.27
1.1
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
55
110
5.37
26.57
1.3
2.0
mg/l
31.3
12.7
1.03
47
99
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
228
1138
2.55
26.57
16.5
2.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
43
68
6.70
26.39
6.0
1.5
pg
33.1
32.7
0.18
43
68
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
75
196
4.20
26.20
3.3
3.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
22
14
16.23
25.50
1.1
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
364
2294
2.35
24.62
25.0
5.5
e9/l
0.1
0.2
15.55
323
2023
(3007164) IgA [Mass/volume] in Serum or Plasma
171
767
2.67
24.57
1.5
1.3
g/l
2.4
2.6
0.81
144
450
(3014148) Varicella zoster virus Ab [Titer] in Serum
28
29
10.05
24.26
1.3
1.1
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
23
0
+∞
24.11
1.8
0.0
%
20.2
—
—
23
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
21
14
15.47
23.74
12.3
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
30
9
34.87
23.53
1.3
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
346
2170
2.28
23.19
27.3
4.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
20
13
15.85
22.88
2.1
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
149
653
2.67
22.21
2.9
1.8
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
176
837
2.52
22.15
2.1
2.4
umol/l
18.3
12.1
11.18
169
766
(3001604) Monocytes [#/volume] in Blood
348
2217
2.24
22.08
21.1
5.3
e9/l
0.7
0.6
0.46
316
1909
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
207
3.79
21.96
1.9
2.4
g/l
3.7
3.7
0.14
50
153
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
208
3.77
21.81
1.9
2.3
g/l
6.6
7.5
3.25
50
156
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
72
208
3.77
21.81
1.9
2.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
348
2225
2.23
21.78
21.2
5.3
e9/l
0.0
0.0
5.92
315
1926
(3034860) Kappa light chains.free [Mass/volume] in Serum
65
175
4.02
21.74
2.1
3.5
mg/l
57.5
99.0
0.54
57
141
(3019198) Lymphocytes [#/volume] in Blood
352
2268
2.22
21.53
21.8
5.4
e9/l
1.8
1.9
0.23
323
2006
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
147
650
2.63
21.46
2.8
1.7
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
24
24
10.35
21.27
2.8
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
24
24
10.35
21.27
2.8
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
184
910
2.43
21.15
17.1
4.6
—
—
—
0
0
(4035726)
104
389
3.00
20.81
1.8
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
22
20
11.35
20.76
1.1
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
20
11.35
20.76
2.3
1.9
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
63
172
3.95
20.65
2.1
3.4
ratio
9.5
2.1
—
5
19
(40760888) Immunoglobulin light chains.free panel - Serum
52
124
4.47
20.37
2.4
3.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
157
737
2.49
20.11
2.1
2.4
%
37.9
21.6
11.33
127
631
(3004789) Transferrin [Mass/volume] in Serum or Plasma
162
776
2.45
19.83
2.0
2.4
g/l
2.0
2.3
11.68
154
707
(3013650) Neutrophils [#/volume] in Blood by Automated count
383
2606
2.16
19.73
48.8
8.5
e9/l
3.3
4.3
1.34
357
2283
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
192
997
2.32
19.54
2.8
1.7
mg/l
3.8
1.4
2.57
167
783
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
62
175
3.81
19.38
2.1
3.5
mg/l
73.8
34.0
0.42
53
144
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
66
195
3.66
19.30
1.9
2.4
g/l
3.2
3.3
0.25
50
156
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
26
34
7.93
18.81
2.7
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
26
34
7.93
18.81
2.7
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
193
3.57
18.14
1.6
2.4
g/l
11.7
10.1
1.10
56
167
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
22
6
37.88
17.71
1.3
5.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
153
750
2.36
17.58
2.1
2.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
14
12.44
16.97
1.0
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
59
178
3.55
16.70
2.0
2.7
g/l
1.2
0.6
0.36
51
154
(3001122) Ferritin [Mass/volume] in Serum or Plasma
297
1928
2.00
16.31
4.8
2.6
ug/l
730.2
150.1
7.30
272
1738
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
15
11
13.94
15.96
1.2
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
15
11
13.94
15.96
1.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
14
10
14.29
15.08
1.4
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
360
2547
1.94
14.91
27.0
5.9
umol/l
13.2
12.3
0.66
349
2400
(3019309) Folate [Moles/volume] in Red Blood Cells
202
1175
2.05
14.80
2.1
1.8
nmol/l
1279.2
1187.7
0.58
166
879
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
355
2529
1.90
14.09
17.3
6.5
mmol/l
1.2
1.2
1.27
297
2100
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
330
2297
1.90
14.07
15.0
5.9
mmol/l
1.2
1.2
2.95
301
2057
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
18
6
30.80
13.94
1.6
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
25
44
5.87
13.77
2.3
1.5
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
13
0
+∞
13.59
1.2
0.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
187
1089
2.01
13.47
2.3
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
225
1402
1.93
13.28
2.6
2.2
mg/l
3.0
3.3
0.78
187
1196
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
31
69
4.67
13.20
1.1
1.3
miu/ml
81.9
307.4
—
5
24
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
37
95
4.07
13.15
1.2
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
52
173
3.18
12.59
1.7
2.5
g/l
36.6
36.8
0.05
45
147
(3044290) Cell count panel - Cerebral spinal fluid
29
65
4.62
12.24
2.7
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
26
55
4.88
11.75
5.4
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
17
9
19.35
11.63
3.2
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
134
3.37
11.57
1.9
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
16
21
7.79
11.46
1.4
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
307
2187
1.77
11.29
15.6
4.5
g/l
32.3
34.6
7.29
287
2020
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
26
57
4.71
11.27
5.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
26
57
4.71
11.27
5.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
26
57
4.71
11.27
5.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
26
57
4.71
11.27
5.5
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
18
28
6.58
11.14
2.3
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
26
58
4.63
11.04
5.5
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
18
29
6.36
10.78
2.3
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
18
29
6.36
10.78
2.3
1.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
36
5.70
10.75
4.5
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
34
5.73
10.27
2.3
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
187
1179
1.83
10.18
12.8
3.9
%
81.2
84.4
0.98
181
1149
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
35
104
3.50
10.14
4.4
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
228
1528
1.76
10.08
14.8
3.9
ph
7.4
7.4
2.16
39
293
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
344
4266
0.58
10.00
4.4
5.1
mmol/l
2.4
2.6
2.87
305
3824
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
7
20.40
9.83
1.4
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
57
229
2.63
9.82
6.7
1.8
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
38
122
3.25
9.77
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
38
122
3.25
9.77
1.6
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
33
97
3.53
9.72
1.5
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
39
128
3.18
9.67
1.3
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
11
10.16
9.56
1.4
1.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
30
84
3.70
9.49
10.5
3.2
%
46.6
60.2
3.90
30
84
(3000494) Fungus identified in Specimen by Culture
98
508
2.10
9.43
3.3
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
23
53
4.46
9.40
3.2
2.1
u/l
2.6
6249.6
—
5
15
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
17
7.78
9.30
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
328
4080
0.60
9.13
5.6
6.4
mmol/mol
40.3
41.2
0.85
295
3708
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
14
21
6.79
8.93
8.2
3.3
u/l
182.6
224.2
2.03
14
21
(40757373) Influenza virus identified in Isolate
10
10
10.14
8.66
1.2
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
16
29
5.63
8.53
2.6
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
336
4097
0.62
7.87
4.1
4.5
mmol/l
1.3
1.4
7.74
295
3673
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
206
1419
1.66
7.87
5.6
3.0
u/l
36.9
34.2
0.20
194
1360
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
49
204
2.52
7.87
3.2
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
337
4093
0.63
7.59
48.1
16.3
ml/min/173m2
77.2
73.7
2.09
284
3422
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
33
4.95
7.44
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
345
4141
0.64
7.04
4.5
4.6
mmol/l
4.1
4.4
6.10
305
3744
(3007853) Bacteria identified in Skin by Aerobe culture
101
585
1.86
7.01
2.0
1.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
40
4.34
6.78
1.5
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
22
63
3.58
6.77
3.0
1.3
u/l
15.8
8.6
0.60
17
54
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
83
456
1.94
6.75
2.0
2.3
g/l
0.2
0.2
0.03
73
422
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
38
151
2.61
6.73
1.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
44
189
2.43
6.63
3.3
2.7
u/ml
0.3
0.4
0.14
21
109
(40758558) Short blood count panel - Blood
169
1155
1.63
6.48
38.0
6.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
62
1132
0.50
6.43
3.0
3.3
ug/l
0.9
0.9
0.05
39
794
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
15
6.76
6.33
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
38
4.29
6.32
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
19
5.87
6.12
1.6
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
8
12.67
6.10
2.2
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
424
4821
0.65
6.09
85.2
24.9
e9/l
9.4
6.9
0.76
405
4662
(3000963) Hemoglobin [Mass/volume] in Blood
424
4820
0.65
6.07
85.9
25.1
g/l
105.7
132.6
92.02
409
4714
(3035941) MCH [Entitic mass]
424
4819
0.65
6.05
84.8
24.8
pg
31.2
30.4
11.05
411
4716
(3026361) Erythrocytes [#/volume] in Blood
424
4819
0.65
6.05
85.2
24.9
e12/l
3.5
4.4
80.74
404
4660
(3007461) Platelets [#/volume] in Blood
424
4818
0.65
6.03
85.4
24.9
e9/l
160.6
239.3
32.12
403
4677
(3019225) pH of Specimen
84
481
1.86
6.02
9.5
4.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
31
4.59
6.01
3.0
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
424
4817
0.65
6.01
85.0
24.9
fl
94.6
91.6
16.95
411
4717
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
64
335
2.01
5.98
1.5
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
396
4559
0.66
5.94
46.4
16.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
20
5.58
5.82
1.3
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
49
234
2.18
5.81
1.5
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
360
4211
0.67
5.70
5.4
4.9
mmol/l
6.1
6.1
0.04
311
3750
(3021788) Differential panel - Synovial fluid
23
76
3.10
5.70
1.5
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
75
1243
0.55
5.60
3.5
3.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
13
29
4.55
5.53
1.2
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
84
501
1.78
5.28
1.3
1.3
titre
560.0
447.9
0.29
23
116
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
407
4623
0.67
5.24
36.9
10.7
u/l
27.0
24.7
1.89
387
4427
(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
5
0
+∞
5.21
7.6
0.0
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
5
0
+∞
5.21
1.2
0.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
107
1585
0.61
5.15
4.0
4.7
%
21.9
21.6
0.08
50
829
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
337
3958
0.69
5.13
4.8
4.1
mmol/l
1.4
1.3
3.64
300
3529
(3032080) INR in Blood by Coagulation assay
276
2209
1.44
4.76
8.8
11.8
inr
1.3
1.3
0.27
66
638
(3023323) Follitropin [Units/volume] in Serum or Plasma
20
69
2.96
4.64
2.8
1.4
iu/l
10.9
25.8
2.23
14
63
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
5
14.13
4.58
2.3
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
5
14.13
4.58
2.3
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
269
2154
1.43
4.58
2.6
2.1
pmol/l
87.4
92.8
1.25
184
1131
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
11
25
4.46
4.57
1.4
1.0
mg/l
28.4
52.1
0.81
11
19
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
21
4.82
4.54
2.4
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
30
131
2.35
4.43
1.5
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
265
3202
0.71
4.40
6.1
4.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
345
2901
1.41
4.38
12.9
4.8
mmol/l
6.9
6.9
0.18
334
2731
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
345
3986
0.71
4.36
5.2
4.6
mu/l
2.0
2.0
0.19
305
3539
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
12
7.59
4.36
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
12
7.59
4.36
1.2
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
22
4.60
4.31
1.1
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
21
78
2.75
4.29
2.0
3.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
15
46
3.31
4.21
1.1
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
14
41
3.47
4.20
1.1
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
141
1014
1.50
4.15
4.4
4.0
ng/l
93.7
295.4
2.05
123
867
(3036481) Cortisol [Moles/volume] in Serum or Plasma
67
402
1.74
4.14
2.3
2.0
nmol/l
376.1
368.6
0.11
67
366
(3051651) Icteric interference index of Serum or Plasma
12
32
3.80
4.10
8.8
3.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
42
218
1.99
4.06
6.5
5.0
mmol/l
25.4
25.0
0.36
37
208
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
17
58
2.98
4.03
3.5
4.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
20
75
2.72
4.02
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
28
124
2.32
4.02
1.5
1.6
iu/ml
0.1
40.2
—
8
30
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
14
6.50
3.99
1.1
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
17
59
2.93
3.92
1.1
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
7
8
8.83
3.78
1.0
1.0
umol/l
14.5
18.2
—
7
8
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
80
517
1.63
3.76
3.2
3.0
ng/l
301.2
272.7
0.25
73
479
(3000475) Leukocytes [#/volume] in Synovial fluid
26
115
2.31
3.76
2.0
1.7
e6/l
13048.5
21398.0
0.60
20
84
(3023103) Potassium [Moles/volume] in Serum or Plasma
418
4636
0.72
3.74
59.4
20.6
mmol/l
4.0
4.0
0.13
405
4493
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
15
50
3.05
3.71
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
153
1985
0.70
3.63
4.5
5.5
ug/l
2.3
3.7
2.40
134
1738
(3002032) Base excess in Venous blood by calculation
79
517
1.60
3.53
4.3
4.2
mmol/l
1.3
1.9
0.54
63
397
(3019550) Sodium [Moles/volume] in Serum or Plasma
419
4631
0.73
3.53
53.1
20.5
mmol/l
138.6
139.6
9.70
403
4487
(3019832) Treponema pallidum Ab [Presence] in Serum
38
202
1.94
3.47
1.5
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
8
14
5.77
3.35
5.1
2.3
mu/l
20.4
10.4
—
8
14
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
14
5.77
3.35
1.3
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
46
267
1.78
3.22
5.8
4.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
33
3.37
3.20
1.1
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
30
151
2.03
3.20
5.7
3.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
230
1879
1.35
3.19
5.4
3.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
191
1523
1.36
3.09
3.5
2.4
u/l
48.3
56.9
3.51
171
1411
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
147
2.02
3.04
1.3
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
113
1506
0.70
3.04
3.4
4.0
mg/mmol
10.2
9.9
0.02
73
964
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
12
5.88
3.02
1.1
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
12
5.88
3.02
1.1
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
310
3543
0.76
3.02
80.4
22.7
g/l
330.4
331.5
1.09
304
3503
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
54
335
1.67
3.00
5.6
4.4
mmol/l
1.4
2.0
0.49
46
254
(3045414) Leukocytes [Presence] in Urine
6
193
0.30
2.99
2.0
2.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
5
10.06
2.98
1.0
1.6
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
5
10.06
2.98
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
69
2.50
2.98
1.1
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
149
1.99
2.94
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
150
1.98
2.89
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
383
0.45
2.88
1.6
1.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
54
339
1.65
2.88
2.9
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
57
363
1.63
2.87
5.5
4.2
kpa
5.2
5.2
0.06
48
336
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
8
18
4.49
2.80
1.4
4.6
%
100.8
99.6
—
8
18
(4062490)
10
31
3.26
2.78
1.6
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
42
2.89
2.76
1.0
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
56
359
1.61
2.75
5.4
4.3
ph
7.4
7.4
—
5
35
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
6
8.39
2.75
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
24
118
2.07
2.75
1.5
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
72
2.40
2.74
1.6
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
114
850
1.41
2.74
4.9
3.2
e6/l
2.8
2.3
0.19
66
510
(3003396) Base excess in Arterial blood by calculation
88
626
1.47
2.72
7.0
7.0
mmol/l
1.1
1.4
0.17
70
481
(3032057) Clostridioides difficile [Presence] in Stool
6
10
6.04
2.70
3.5
1.5
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
10
6.04
2.70
1.2
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
79
2.32
2.70
1.0
1.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
88
628
1.46
2.67
6.1
6.9
kpa
10.6
11.5
1.08
83
601
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
44
267
1.70
2.67
8.7
9.8
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
107
1410
0.71
2.66
2.6
3.2
mg/l
1233.6
217.6
0.66
76
924
(3016502) Oxygen saturation in Arterial blood
81
570
1.48
2.64
7.2
7.2
%
93.5
95.1
0.71
76
545
(3019060) Gas panel - Arterial blood
60
397
1.56
2.60
4.9
4.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
112
1459
0.72
2.59
2.6
3.1
mmol/l
6.7
7.2
0.51
99
1189
(3009871) Measles virus Ab [Titer] in Serum
5
7
7.19
2.55
1.8
1.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
25
130
1.96
2.48
1.5
1.4
g/l
0.2
0.2
0.49
25
125
(4027681)
8
21
3.84
2.47
1.3
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
76
2.27
2.46
1.2
1.1
—
1.2
—
0
5
(3026008) Bacteria identified in Urine by Culture
199
1650
1.30
2.38
4.8
3.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
17
4.15
2.36
1.0
1.1
nmol/l
107.1
125.0
—
7
17
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
17
4.15
2.36
1.0
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
9
216
0.41
2.35
2.9
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
219
0.40
2.34
2.3
1.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
45
286
1.62
2.32
3.8
2.9
e9/l
3.9
4.1
0.10
33
212
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
13
4.65
2.27
1.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
13
4.65
2.27
1.2
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
13
4.65
2.27
1.0
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
66
2.30
2.26
1.1
1.3
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
25
135
1.89
2.25
1.5
1.4
g/l
1.2
1.1
0.14
25
129
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
287
3242
0.79
2.23
4.5
3.7
pmol/l
14.8
15.0
0.44
255
2857
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
17
80
2.16
2.20
1.2
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
48
2.53
2.19
1.3
1.2
u/ml
1.8
1.5
—
5
16
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
150
0.33
2.17
2.8
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
64
448
1.48
2.17
2.6
2.3
u/l
33.8
31.9
0.16
55
371
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
14
4.32
2.15
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
207
1746
1.27
2.13
3.5
3.3
ng/l
2188.5
2113.0
0.08
193
1522
(3023419) Bacteria identified in Sputum by Culture
15
68
2.23
2.12
2.7
3.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
32
2.84
2.00
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
32
2.84
2.00
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
32
2.84
2.00
1.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
77
2.11
1.98
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
241
0.45
1.96
2.2
2.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
51
2.38
1.96
9.0
3.7
—
—
—
0
0
(3017704) Immunofixation for Urine
9
33
2.75
1.93
1.0
1.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
33
2.75
1.93
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
33
2.75
1.93
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
33
2.75
1.93
1.0
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
61
838
0.70
1.92
1.3
1.2
u/ml
4.5
1.4
0.47
14
219
(3000330) Specific gravity of Urine by Test strip
15
290
0.51
1.89
6.1
4.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
19
339
0.55
1.86
2.4
3.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
6
17
3.55
1.84
11.7
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
229
1990
1.23
1.77
40.3
10.0
e9/l
0.2
0.0
0.60
194
1626
(3015377) Calcium [Moles/volume] in Serum or Plasma
198
1695
1.24
1.75
5.0
3.3
mmol/l
2.3
2.3
4.31
171
1449
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
203
1.61
1.71
1.4
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
190
1625
1.24
1.69
5.3
3.5
e6/l
225.4
130.0
0.26
155
1297
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
42
2.40
1.68
1.1
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
31
2.60
1.66
1.0
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
59
430
1.41
1.66
4.0
3.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
49
2.27
1.64
1.2
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
28
174
1.64
1.63
1.4
2.0
u/l
31.4
39.4
1.25
22
150
(3000991) Gas panel - Venous blood
59
432
1.40
1.62
9.2
8.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
157
1324
1.25
1.58
1.9
1.6
nmol/l
19.8
20.1
0.12
147
1111
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
419
4468
0.82
1.57
62.6
17.2
mg/l
35.0
27.0
3.75
393
3692
(36304419) Bacteria [Presence] in Urine
162
1374
1.24
1.55
5.4
3.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
183
0.48
1.53
1.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
27
2.61
1.52
1.9
1.6
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
7
27
2.61
1.52
1.6
1.2
mmol/l
3.3
1.9
—
7
27
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
9
37
2.45
1.48
1.0
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
350
3219
1.19
1.42
6.9
5.1
e6/l
226.2
3519.3
—
10
69
(3014271) Vancomycin [Susceptibility]
9
41
2.21
1.37
4.4
2.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
389
3617
1.19
1.37
32.1
7.3
u/l
83.6
82.6
0.19
375
3357
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
23
2.62
1.37
1.2
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
120
1.69
1.35
1.5
1.9
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
37
0.00
1.34
0.0
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
24
2.51
1.30
1.0
1.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
70
1.87
1.24
1.3
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
20
125
1.62
1.19
5.4
3.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
38
2.12
1.18
2.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
38
2.12
1.18
2.1
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
50
2.02
1.17
1.4
2.2
—
—
—
0
0
(4306422)
8
39
2.06
1.15
1.0
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
166
1456
1.19
1.12
5.4
3.4
e6/l
0.5
0.6
0.51
131
1136
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
105
881
1.23
1.12
4.8
3.0
e6/l
1.2
1.1
0.04
58
535
(3038177) Helicobacter pylori Ab [Presence] in Serum
8
41
1.96
1.09
1.4
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
203
2256
0.85
1.09
3.3
2.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
192
0.57
1.07
1.3
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
129
1115
1.20
1.03
4.4
3.0
mosm/kgh2o
540.7
563.7
0.72
120
944
(3020891) Body temperature
30
214
1.42
1.01
6.1
4.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
376
0.71
0.99
4.9
3.1
ml/min/173m2
57.7
59.0
0.06
13
164
(3045788) Cell count panel - Pleural fluid
11
61
1.82
0.99
1.5
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
361
3827
0.87
0.97
59.9
18.6
%
31.7
38.6
23.76
207
2457
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
30
0.00
0.97
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
202
1824
1.16
0.95
6.3
4.0
e6/l
77.2
172.5
1.13
160
1376
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
40
305
1.33
0.93
10.1
9.3
%
0.7
0.7
0.19
40
300
(21494890) Protein electrophoresis panel - 24 hour Urine
9
52
1.74
0.92
1.6
2.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
42
324
1.32
0.90
2.7
2.9
e6/l
1.0
0.3
0.55
42
317
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
6
30
2.01
0.87
2.2
1.4
%
55.7
68.1
—
6
19
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
131
1154
1.17
0.85
1.6
1.8
pmol/l
120388868.5
6090174.9
0.46
103
936
(3023511) Choriogonadotropin [Units/volume] in Urine
6
31
1.94
0.84
1.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
29
214
1.37
0.84
1.4
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
114
0.52
0.83
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
46
1.75
0.82
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
46
1.75
0.82
1.5
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
131
1157
1.17
0.82
3.9
2.7
e6/l
5.6
4.5
1.07
122
1018
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
40
312
1.30
0.81
10.0
9.0
%
1.5
1.4
0.17
40
307
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
14
212
0.65
0.81
2.9
3.3
u/ml
10.7
14408.2
0.60
14
176
(3026389) Candida sp identified in Specimen by Organism specific culture
10
58
1.74
0.80
1.7
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
109
1242
0.85
0.79
4.0
3.9
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
6
33
1.83
0.79
1.0
1.1
—
120.0
—
0
6
(3010144) Erythrocytes [#/volume] in Synovial fluid
8
48
1.67
0.79
2.3
1.3
e6/l
30444.9
240368.5
—
8
34
(40768797) Stomach Pathology biopsy report
69
580
1.21
0.76
1.3
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
28
0.00
0.76
0.0
1.4
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
5
27
1.86
0.68
2.4
1.3
%
1.8
1.5
—
5
20
(40768806) Pleura Pathology biopsy report
12
78
1.55
0.66
1.5
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
30
1.67
0.61
4.6
16.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
209
2242
0.90
0.61
6.3
5.7
estimate
0.0
0.0
0.00
39
429
(3015171) Extractable nuclear Ab [Units/volume] in Serum
18
131
1.38
0.59
1.3
1.3
—
1.6
—
0
12
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
23
175
1.33
0.59
3.8
3.3
u/ml
30.0
62.9
0.76
23
166
(36660697) Celiac disease serology panel - Serum
21
274
0.76
0.57
1.3
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
213
2272
0.91
0.55
4.5
4.3
estimate
0.0
0.0
0.00
36
429
(4268621)
6
39
1.54
0.53
3.0
2.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
163
1758
0.90
0.52
4.6
4.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
40
1.50
0.51
1.0
2.0
%
7.8
10.5
—
6
40
(4034850)
10
145
0.68
0.51
17.0
12.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
33
400
0.82
0.51
2.0
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
38
453
0.83
0.50
1.3
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
53
611
0.86
0.48
1.2
1.3
u/ml
1.0
13.0
3.98
14
227
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
56
487
1.16
0.47
2.5
2.7
ug/l
3.3
6.2
2.23
44
425
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
219
2066
1.09
0.47
4.1
4.3
ng/l
31.4
48.5
2.76
170
1574
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
43
366
1.19
0.46
1.5
1.6
%
1.7
1.5
0.84
33
312
(3015183) Erythrocyte sedimentation rate
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
9.0
—
0
15
(3020961) Endomysium IgA Ab [Titer] in Serum
14
183
0.76
0.41
1.1
1.1
titre
—
32.2
—
0
5
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
0.9
—
0
7
(3037556) Urate [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
21
170
1.24
0.37
6.3
3.8
mmol/l
3.7
3.9
0.94
21
152
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
66
593
1.13
0.37
13.6
8.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
214
2246
0.93
0.37
4.5
4.2
estimate
0.0
0.0
0.00
42
439
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
59
528
1.13
0.36
1.4
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
126
1.28
0.35
1.3
1.4
ug/g
247.3
281.0
0.30
11
75
(3035880) pH of Pleural fluid
6
43
1.40
0.35
1.8
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
43
1.40
0.35
1.3
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
199
1896
1.07
0.33
2.6
2.2
nmol/l
76.6
77.1
0.09
176
1653
(3027008) Opiates [Presence] in Urine
6
86
0.69
0.33
2.0
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
86
0.69
0.33
2.0
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
87
802
1.10
0.32
18.9
29.2
inr
1.3
1.5
0.43
15
100
(3013707) Erythrocyte sedimentation rate by Westergren method
348
3381
1.06
0.32
5.2
4.1
mm/h
26.0
14.3
13.36
320
3069
(3002256) Pathology report gross observation
54
599
0.89
0.31
1.7
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
7
98
0.71
0.31
1.0
1.1
—
15.2
—
0
10
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
62
1.29
0.28
2.5
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
59
645
0.91
0.27
1.1
1.3
iu/ml
15.2
37.1
3.98
17
210
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
121
0.74
0.27
2.1
2.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
14
113
1.24
0.27
2.6
2.2
%
15.0
15.7
—
6
51
(3003327) Ova and parasites identified in Stool by Light microscopy
12
95
1.27
0.26
1.8
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
273
1.14
0.25
3.1
2.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
87
1.27
0.24
1.1
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
159
1522
1.06
0.24
2.6
2.1
u/l
120.0
343.0
2.59
146
1419
(3027456) Digoxin [Moles/volume] in Serum or Plasma
17
143
1.19
0.23
2.2
3.3
nmol/l
0.8
0.9
0.71
12
115
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.0
—
2.8
—
0
5
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
10
0.00
0.21
0.0
8.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
14
0.00
0.20
0.0
1.4
—
3.3
—
0
14
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
113
0.79
0.20
3.1
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
97
1020
0.94
0.19
3.2
3.2
mmol/l
2.4
2.5
0.86
87
887
(3024928) Oxygen saturation in Venous blood
13
109
1.20
0.18
1.5
2.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
60
1.17
0.18
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
24
214
1.13
0.17
1.5
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
61
1.15
0.17
2.3
2.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
10
82
1.22
0.17
1.5
2.3
%
53.9
59.8
—
10
82
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
68
0.73
0.17
1.0
1.1
—
—
—
0
0
(4010399)
27
298
0.90
0.16
1.6
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
130
0.84
0.16
1.8
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
78
0.77
0.15
2.5
2.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
25
275
0.91
0.15
3.3
4.2
%
52.4
45.5
0.72
25
270
(3011397) Hemoglobin [Presence] in Urine by Test strip
108
1041
1.05
0.14
4.6
4.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
104
1.16
0.12
2.6
2.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
16
179
0.89
0.12
5.2
5.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
98
1014
0.96
0.11
4.5
4.8
kg/l
1.0
1.0
0.25
15
153
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
60
573
1.05
0.11
3.4
4.7
%
29.7
32.5
0.83
40
365
(4281824)
5
44
1.14
0.10
1.4
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
5
44
1.14
0.10
3.0
1.3
%
16.5
25.2
—
5
34
(3013512) EKG study
146
1493
0.97
0.09
4.8
4.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
47
1.06
0.09
4.0
3.1
nmol/l
6.9
7.2
—
5
47
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
64
1.09
0.08
1.4
1.9
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
7
65
1.08
0.08
1.9
2.0
pmol/l
174.3
253.1
—
7
59
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
65
1.08
0.08
2.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
84
0.83
0.07
1.9
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
85
0.82
0.07
2.0
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
57
551
1.04
0.07
7.6
4.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
93
0.86
0.06
3.4
2.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
27
257
1.05
0.05
2.3
2.7
%
0.7
0.7
0.34
27
252
(40768804) Tissue Pathology biopsy report
174
1762
0.98
0.05
2.6
2.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
110
0.91
0.05
1.1
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
12
130
0.92
0.04
2.5
2.4
ug/min
65.7
98.4
—
6
78
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
265
2633
1.01
0.03
4.2
3.1
u/l
76.0
54.0
2.02
240
2408
(3029937) Albumin [Presence] in Urine by Test strip
126
1273
0.99
0.03
4.4
4.5
estimate
0.0
0.0
0.00
35
418
(3013139) Helicobacter pylori Ag [Presence] in Stool
24
231
1.04
0.03
1.0
1.3
—
—
—
0
0
(3000492) Spirometry study
36
351
1.03
0.02
1.7
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
18
188
0.96
0.02
1.6
3.2
g/l
0.2
0.3
—
7
72
(40761536) Microorganisms panel - Urine sediment
41
401
1.02
0.02
4.6
3.9
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
127
0.94
0.01
1.3
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
15
143
1.05
0.01
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
325
3241
1.01
0.01
6.7
4.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
246
1.02
0.00
2.3
3.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
44
437
1.01
0.00
1.7
2.0
ug/g
106.5
138.0
0.76
35
345
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
56
558
1.00
0.00
2.9
4.0
ug/l
3.5
34.5
1.43
45
476
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
9
0.00
0.00
0.0
7.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
81
0.99
0.00
1.4
1.1
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
8
0.00
0.00
0.0
2.9
—
9112.3
—
0
8
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.1
—
93.4
—
0
7
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
62
0.97
0.00
1.8
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
96
0.94
0.00
1.7
1.9
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
9.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.3
—
5.4
—
0
7
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
7
70
1.00
0.00
1.1
3.3
—
28.0
—
0
20
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
16.4
—
0
6
(3011288) Drugs identified in Urine by Screen method
5
51
0.98
0.00
3.0
1.4
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
44.8
—
0
5
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.7
—
—
—
0
0
(3025315) Body weight
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_AML_MDS – Acute myeloid leukaemia and myelodysplastic syndromes
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).